n,n-dimethylarginine has been researched along with epoetin alfa in 2 studies
Studies (n,n-dimethylarginine) | Trials (n,n-dimethylarginine) | Recent Studies (post-2010) (n,n-dimethylarginine) | Studies (epoetin alfa) | Trials (epoetin alfa) | Recent Studies (post-2010) (epoetin alfa) |
---|---|---|---|---|---|
2,216 | 228 | 1,221 | 1,889 | 388 | 452 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Desai, A; Warren, JS; Zhao, Y | 1 |
Calò, LA; Davis, PA | 1 |
2 other study(ies) available for n,n-dimethylarginine and epoetin alfa
Article | Year |
---|---|
Human recombinant erythropoietin augments serum asymmetric dimethylarginine concentrations but does not compromise nitric oxide generation in mice.
Topics: Amidohydrolases; Animals; Arginine; Base Sequence; Cells, Cultured; DNA Primers; Endothelial Cells; Epoetin Alfa; Erythropoietin; Humans; Kidney; Kidney Failure, Chronic; Liver; Male; Mice; Mice, Inbred BALB C; Nitric Oxide; Nitric Oxide Synthase Type II; Recombinant Proteins; Up-Regulation; Vascular Diseases | 2008 |
EPO induces rise in serum ADMA but does not prevent the increase in NO release: the likely involvement of HO-1.
Topics: Animals; Apoptosis; Arginine; Endothelium, Vascular; Epoetin Alfa; Erythropoietin; Heme Oxygenase-1; Humans; Kidney Failure, Chronic; Nitric Oxide; Nitric Oxide Synthase; Recombinant Proteins; Renal Dialysis | 2008 |